Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy

Abstract

Dual blockade of the RAS may offer additional renal and cardiovascular protection in type 1 patients with DN responding insufficiently to conventional antihypertensive therapy, including recommended doses of ACEI and diuretics.